Shanghai UniXell Biotechnology
PrivateLast Round
Series A
Apr 18, 2025
Total Funding Raised
$71.38M
Company Overview
Shanghai UniXell Biotechnology is a biotechnology company that develops human pluripotent stem cell (hPSC) based cell therapies for neurodegenerative and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai UniXell Biotechnology Comps
Public and private peers based on sector, stage, and business model.
Shanghai UniXell Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 18, 2025 | ||||
| Series A | Jul 12, 2024 | ||||
| Series A | Apr 4, 2024 | ||||
| Pre Seed | Mar 14, 2022 | ||||
| Angel | Aug 25, 2021 |
Shanghai UniXell Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guokejiahe Fund | Series A |
| TF Capital | Pre Seed |
| CAS Venture Capital | Series A |
| GL Ventures | Pre Seed |
| Jiangsu Ruihua Investment Holding Group | Pre Seed |
| Kunlun Capital | Series A |
| Tasly Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2025
$19.18M round with participation from Guokejiahe Fund and Kunlun Capital.
- Jul 12, 2024
$1.38M round led by The Chinese Academy of Sciences Venture Capital Management
Shanghai UniXell Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai UniXell Biotechnology's valuation, stock price, and market status.
